Jessica Macleod, MD
Obstetrics & Gynecology · Austin, TXNPI 1740498492
Payments from drug & device makers
Across 49 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$240
- Astellas Pharma US Inc$190
- Mayne Pharma Commercial LLC$112
- Organon$53
- Daiichi Sankyo Inc.$52
- Coopersurgical, Inc.$34
- plus $278 from 14 others
What the payments were for
- Food & beverage$959100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 14 | $240 |
| Astellas Pharma US Inc | 8 | $190 |
| Mayne Pharma Commercial LLC | 5 | $112 |
| Organon | 2 | $53 |
| Daiichi Sankyo Inc. | 2 | $52 |
| Coopersurgical, Inc. | 2 | $34 |
| Coloplast | 1 | $33 |
| Exeltis, USA Inc. | 2 | $32 |
| Aspira Women's Health Inc | 2 | $29 |
| Exact Sciences | 1 | $24 |
| Duchesnay USA Incorporated | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $19 |
| BD | 1 | $19 |
| Scynexis, Inc. | 1 | $18 |
| Lupin Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| Millicent US Inc | 1 | $14 |
| Merck | 1 | $13 |
| Channel Medsystems, Inc. | 1 | $7 |
How this compares
$959 in reported general payments places this provider in the 50th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Climara ProEstradiol/Levonorgestrel | 11 | $3,069 |
| Estradiol | 32 | $1,237 |
| Alendronate Sodium | 13 | $186 |
| Clobetasol Propionate | 12 | $172 |
| ValacyclovirValacyclovir Hcl | 17 | $153 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Melissa WinnAustin$1.1M
- Laura DowningAustin$464K
- Ana EduardoAustin$303K
- Stephanie ReichAustin$249K
- Renu ChalasaniAustin$156K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.